Optimal Dose of Extracorporeal Shock Wave Therapy After Botulinum Toxin Type A Injection for Post-stroke Spasticity

Post-Stroke Elbow Spasticity Clinical Trial

Status Recruiting

Clinical Trial Summary

Recently, It is known that the efficacy of botulinum toxin type A (BTX-A) with extracorporeal shock wave therapy (ESWT) is greater than that of BTX-A with electrical stimulation in the management of post-stroke spasticity of the upper limb. However, it was not determined which dose of ESWT is optimal as a adjuvant therapy after BTX-A injection on the upper limb in patients with stroke. Therefore, the aim of this study is to evaluate the optimal dose of ESWT after botulinum toxin type A injection for post-stroke spasticity

Clinical Trial Description

n/a

Related Conditions & MeSH terms

• Muscle Spasticity
• Post-Stroke Elbow Spasticity
• Stroke

• NCT number: NCT02358005
• Study type: Interventional
• Source: Yonsei University
• Contact: Yong Wook Kim, MD
• Phone: +82 -2-2228-3716
• Email: YWKIM1@yuhs.ac
• Status: Recruiting
• Phase: Phase 4
• Start date: February 2015
• Completion date: August 2019